344 transgenic expression of CD40 ligand (CD40L) produces an in vivo antitumor immune response against both CD40 positive and negative plasmacytoma cells

344 Transgenic Expression of CD40 Ligand (CD40L) Produces an In Vivo Antitumor Immune Response Against Both CD40 Positive and Negative Plasmacytoma Cells Molecular Therapy Vol 5, No 5, May 2002, Part[.]

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

S114

NON-VIRAL IMMUNOTHERAPY

6H   !C'"   >7    89978 A&B, *A   O 89H

342 Engineering Neural Stem Progenitor Cells T

342 Engineering Neural Stem Progenitor Cells To o

Release Therapeutic Factors for Malignant Gliomas

Patrizia Tunici, 1 Davide Gianni, 1 Gaetano Finocchiaro 1

1 Experimental Neurology, Istituto Neurologico Besta, Milano, Italy.

343 Genetic Delivery of a Single Chain Fv Fragment

(scFv) Specific to a T

(scFv) Specific to a Tumour umour umour Associated Associated Associated Antigen (T Antigen (T Antigen (TAA) for AA) for

T

Targeting Humoral and Cellular Immune Responses to argeting Humoral and Cellular Immune Responses to

T

Tumours umoursIn V In Vivo ivo

Abigail Lamikanra, 1 Kevin A Myers, 1 Matthew G Ryan, 1 Susan M.

Kingsman, 1 Miles W Carroll 1

1 Tumour Immunotherapy, Oxford BioMedica, Oxford, Oxfordshire,

United Kingdom.

8

344 T

344 Transgenic Expression of CD40-Ligand (CD40L) ransgenic Expression of CD40-Ligand (CD40L) Produces an In Vivo Antitumor Immune Response Against Both CD40 Positive and Negative Plasmacytoma Cells

Gianpietro Dotti, 1 Barbara Savoldo, 1 Patricia Yotnda, 1 Donna Rill, 1

Malcolm Brenner 1

1 Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, United States.

Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts

NON-VIRAL IMMUNOTHERAPY

345 Expression of Ig Heavy Chain Fc in T

345 Expression of Ig Heavy Chain Fc in Tumor Cells to umor Cells to

Enhance T

Enhance Tumor Immunogenicity through Multiple umor Immunogenicity through Multiple

Immunological Effector Pathways

David Riddle, 1 Richard Vile 1

1 Molecular Medicine Program, Mayo Clinic, Rochester, MN,

United States.

346 Alternative Forms of the Cytochrome P450

Protein Induce T-Cell Responses in Immunized Mice

Bijan A Etemad-Moghadam, Lisa Baker, Geoffrey Cole, Urban

Ramstedt, Olive Yuan, Mary Lynne Hedley.

1 ZYCOS Inc., Lexington, MA, United States.

347 Intratumoral Immunization with T

347 Intratumoral Immunization with Tumor RNA umor RNA Pulsed Dendritic Dells Enhances Antitumor Immunity Against Exocrine Ductal Carcinoma in C57BL/6 Mice

Carsten G Ziske, 1 Tanja Schmidt, 1 Angela Maerten, 1 Tilmann Sauerbruch, 1 John Strehl, 1 Ingo G H Schmidt-Wolf 1

1 Medizinische Universitätsklinik I, Rhein Friedrichs-Wilhelmsuniversität, Bonn, Germany.

348

348 A A A Sensitive Method for T Sensitive Method for T Sensitive Method for Treatment Monitoring of reatment Monitoring of Microscopic Ovarian Cancer in Live Mice

T R Chaudhuri, 1 Z Cao, 1 D L Della Manna, 2 C Rodriguez-Burford, 1 E E Partridge, 3 K R Zinn 1

1 Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, United States; 2 Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States; 3 Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States.

;